Cargando…
Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy
Several recent studies have reported that gold nanoparticles (AuNPs) attenuate hyperglycemia in diabetic animal models without any observed side effects. The present study was intended to provide insight into the effects of 50-nm AuNPs on diabetic kidney disease. Adult male rats were divided into th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978433/ https://www.ncbi.nlm.nih.gov/pubmed/31637677 http://dx.doi.org/10.1007/s13346-019-00675-6 |
_version_ | 1783490699399790592 |
---|---|
author | Alomari, Ghada Al-Trad, Bahaa Hamdan, Salehhuddin Aljabali, Alaa Al-Zoubi, Mazhar Bataineh, Nesreen Qar, Janti Tambuwala, Murtaza M. |
author_facet | Alomari, Ghada Al-Trad, Bahaa Hamdan, Salehhuddin Aljabali, Alaa Al-Zoubi, Mazhar Bataineh, Nesreen Qar, Janti Tambuwala, Murtaza M. |
author_sort | Alomari, Ghada |
collection | PubMed |
description | Several recent studies have reported that gold nanoparticles (AuNPs) attenuate hyperglycemia in diabetic animal models without any observed side effects. The present study was intended to provide insight into the effects of 50-nm AuNPs on diabetic kidney disease. Adult male rats were divided into three groups (n = 7/group): control (non-diabetic, ND), diabetic (D), and diabetic treated intraperitoneally with 50-nm AuNPs (AuNPs + D; 2.5 mg/kg/day) for 7 weeks. Diabetes was induced by a single-dose injection of 55 mg/kg streptozotocin. The result showed that AuNP treatment prevented diabetes-associated increases in the blood glucose level. Reduction in 24-h urinary albumin excretion rate, glomerular basement membrane thickness, foot process width, and renal oxidative stress markers was also demonstrated in the AuNP-treated group. In addition, the results showed downregulation effect of AuNPs in renal mRNA or protein expression of transforming growth factor β1 (TGF-β(1)), fibronectin, collagen IV, tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor-A (VEGF-A). Moreover, the protein expression of nephrin and podocin, podocyte markers, in glomeruli was increased in the AuNPs + D group compared with the D group. These results provide evidence that 50-nm AuNPs can ameliorate renal damage in experimental models of diabetic nephropathy through improving the renal function and downregulating extracellular matrix protein accumulation, along with inhibiting renal oxidative stress and amelioration of podocyte injury. |
format | Online Article Text |
id | pubmed-6978433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-69784332020-02-03 Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy Alomari, Ghada Al-Trad, Bahaa Hamdan, Salehhuddin Aljabali, Alaa Al-Zoubi, Mazhar Bataineh, Nesreen Qar, Janti Tambuwala, Murtaza M. Drug Deliv Transl Res Original Article Several recent studies have reported that gold nanoparticles (AuNPs) attenuate hyperglycemia in diabetic animal models without any observed side effects. The present study was intended to provide insight into the effects of 50-nm AuNPs on diabetic kidney disease. Adult male rats were divided into three groups (n = 7/group): control (non-diabetic, ND), diabetic (D), and diabetic treated intraperitoneally with 50-nm AuNPs (AuNPs + D; 2.5 mg/kg/day) for 7 weeks. Diabetes was induced by a single-dose injection of 55 mg/kg streptozotocin. The result showed that AuNP treatment prevented diabetes-associated increases in the blood glucose level. Reduction in 24-h urinary albumin excretion rate, glomerular basement membrane thickness, foot process width, and renal oxidative stress markers was also demonstrated in the AuNP-treated group. In addition, the results showed downregulation effect of AuNPs in renal mRNA or protein expression of transforming growth factor β1 (TGF-β(1)), fibronectin, collagen IV, tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor-A (VEGF-A). Moreover, the protein expression of nephrin and podocin, podocyte markers, in glomeruli was increased in the AuNPs + D group compared with the D group. These results provide evidence that 50-nm AuNPs can ameliorate renal damage in experimental models of diabetic nephropathy through improving the renal function and downregulating extracellular matrix protein accumulation, along with inhibiting renal oxidative stress and amelioration of podocyte injury. Springer US 2019-10-21 2020 /pmc/articles/PMC6978433/ /pubmed/31637677 http://dx.doi.org/10.1007/s13346-019-00675-6 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Alomari, Ghada Al-Trad, Bahaa Hamdan, Salehhuddin Aljabali, Alaa Al-Zoubi, Mazhar Bataineh, Nesreen Qar, Janti Tambuwala, Murtaza M. Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
title | Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
title_full | Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
title_fullStr | Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
title_full_unstemmed | Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
title_short | Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
title_sort | gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978433/ https://www.ncbi.nlm.nih.gov/pubmed/31637677 http://dx.doi.org/10.1007/s13346-019-00675-6 |
work_keys_str_mv | AT alomarighada goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT altradbahaa goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT hamdansalehhuddin goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT aljabalialaa goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT alzoubimazhar goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT batainehnesreen goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT qarjanti goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy AT tambuwalamurtazam goldnanoparticlesattenuatealbuminuriabyinhibitingpodocyteinjuryinaratmodelofdiabeticnephropathy |